GNE-6468 is primarily utilized in the field of oncology research, where it serves as a potent inhibitor targeting specific proteins involved in cancer cell proliferation. Its application is focused on preclinical studies aimed at understanding and disrupting the signaling pathways that contribute to tumor growth and survival. Researchers employ this compound to investigate its efficacy in inducing apoptosis in cancer cells and its potential to enhance the effectiveness of existing cancer therapies. Additionally, GNE-6468 is explored for its role in combination treatments, where it may synergize with other therapeutic agents to improve outcomes in various cancer models. Its development underscores the ongoing efforts to identify novel compounds that can offer more targeted and less toxic options for cancer treatment.